Predictive Oncology (NASDAQ:POAI) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.09) by 144.44 percent. This is a 58.49 percent increase over losses of $(0.53) per share from the same period last year. The company reported $2.682 thousand in sales this quarter. This is a 96.01 percent decrease over sales of $67.255 thousand the same period last year.